Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial

About this Attention Score

• In the top 25% of all research outputs scored by Altmetric
• High Attention Score compared to outputs of the same age (83rd percentile)
• Good Attention Score compared to outputs of the same age and source (76th percentile)